SANDU PHARMACEUTICALS LTD.

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	49.42	49.16	43.67	46.81	44.92
Other Income	0.57	0.12	0.56	0.12	0.14
Stock Adjustments	1.57	0.91	-0.81	0.58	-1.44
Total Income	51.56	50.19	43.42	47.51	43.62
EXPENDITURE :
Raw Materials	26.91	29.36	24.83	21.86	20.59
Excise Duty	0	0.14	0.85	0.73	0.51
Power and Fuel Cost	0.33	0.32	0.23	0.4	0.51
Other Manufacturing Expenses	4.03	3.43	3.16	0.96	0.57
Employee Cost	6.49	5.94	5.42	4.51	3.69
Selling and Administration Expenses	10.79	8.19	6.31	15.7	14.09
Miscellaneous Expenses	0.36	0.23	0.21	0.32	1.09
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	2.66	2.59	2.41	3.01	2.57
Interest and Financial Charges	1.01	1.23	1.49	1.64	1.37
Profit before Depreciation and Tax	1.65	1.36	0.92	1.37	1.2
Depreciation	0.64	0.6	0.87	0.69	0.57
Profit Before Tax	1.02	0.75	0.06	0.68	0.63
Tax	0.35	0.19	0.5	0.14	0.22
Profit After Tax	0.67	0.56	-0.44	0.54	0.41
Adjustment below Net Profit	0	0	0	0	0
P and L Balance brought forward	1.61	0.91	1.21	1.56	1.15
Appropriations	-0.14	-0.14	-0.14	0	0
P and L Bal. carried down	2.41	1.61	0.91	2.1	1.56
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	0	0	0	0	0
Earning Per Share (Rs.)	0.94	0.79	0	0.76	0.58
Book Value	27.39	26.2	25.05	26.39	25.63
Extraordinary Items	0	0.04	-0.57	-0.02	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

49.42

49.16

43.67

46.81

44.92

Other Income

0.57

0.12

0.56

0.12

0.14

Stock Adjustments

1.57

0.91

-0.81

0.58

-1.44

Total Income

51.56

50.19

43.42

47.51

43.62

EXPENDITURE :

Raw Materials

26.91

29.36

24.83

21.86

20.59

Excise Duty

0.14

0.85

0.73

0.51

Power and Fuel Cost

0.33

0.32

0.23

0.4

0.51

Other Manufacturing Expenses

4.03

3.43

3.16

0.96

0.57

Employee Cost

6.49

5.94

5.42

4.51

3.69

Selling and Administration Expenses

10.79

8.19

6.31

15.7

14.09

Miscellaneous Expenses

0.36

0.23

0.21

0.32

1.09

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

2.66

2.59

2.41

3.01

2.57

Interest and Financial Charges

1.01

1.23

1.49

1.64

1.37

Profit before Depreciation and Tax

1.65

1.36

0.92

1.37

1.2

Depreciation

0.64

0.6

0.87

0.69

0.57

Profit Before Tax

1.02

0.75

0.06

0.68

0.63

Tax

0.35

0.19

0.5

0.14

0.22

Profit After Tax

0.67

0.56

-0.44

0.54

0.41

Adjustment below Net Profit

P and L Balance brought forward

1.61

0.91

1.21

1.56

1.15

Appropriations

-0.14

P and L Bal. carried down

2.41

1.61

0.91

2.1

1.56

Equity Dividend

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

0.94

0.79

0.76

0.58

Book Value

27.39

26.2

25.05

26.39

25.63

Extraordinary Items

0.04

-0.57

-0.02

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	7.08	7.08	7.08	7.08	7.08
Reserves and Surplus	21.7	21	20.33	11.6	11.06
Total Shareholders Funds	28.78	28.08	27.41	18.68	18.14
Secured Loans	6.17	9.42	10.02	10.83	11.88
Unsecured Loans	0	0	0.54	0.56	0.59
Total Debt	6.17	9.42	10.56	11.39	12.47
Total Liabilities	34.95	37.5	37.97	30.07	30.61
APPLICATION OF FUNDS :
Gross Block	25.78	25.67	25.13	14.5	14.36
Less: Accum. Depreciation	8.73	8.1	7.64	6.69	6
Net Block	17.05	17.57	17.49	7.81	8.36
Capital Work in Progress	0	0	0	0	0
Investments	1.13	1.12	0.99	0.73	0.7
Current Assets, Loans and Advances
Inventories	13.26	11.44	10.68	12.04	12.68
Sundry Debtors	4.8	6.69	6.35	7.15	6.56
Cash and Bank Balance	0.79	1.41	2.69	0.69	4.13
Loans and Advances	6.64	6.3	8.4	12.98	9.09
Less: Current Liab. and Prov.
Current Liabilities	6.11	4.93	5.99	8.15	8.81
Provisions	2.58	2.11	2.64	3.19	2.09
Net Current Assets	16.8	18.8	19.49	21.52	21.56
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	34.98	37.49	37.97	30.06	30.62
Contingent Liabilities	0	0	0	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

7.08

Reserves and Surplus

21.7

20.33

11.6

11.06

Total Shareholders Funds

28.78

28.08

27.41

18.68

18.14

Secured Loans

6.17

9.42

10.02

10.83

11.88

Unsecured Loans

0.54

0.56

0.59

Total Debt

6.17

9.42

10.56

11.39

12.47

Total Liabilities

34.95

37.5

37.97

30.07

30.61

APPLICATION OF FUNDS :

Gross Block

25.78

25.67

25.13

14.5

14.36

Less: Accum. Depreciation

8.73

8.1

7.64

6.69

Net Block

17.05

17.57

17.49

7.81

8.36

Capital Work in Progress

Investments

1.13

1.12

0.99

0.73

0.7

Current Assets, Loans and Advances

Inventories

13.26

11.44

10.68

12.04

12.68

Sundry Debtors

4.8

6.69

6.35

7.15

6.56

Cash and Bank Balance

0.79

1.41

2.69

0.69

4.13

Loans and Advances

6.64

6.3

8.4

12.98

9.09

Less: Current Liab. and Prov.

Current Liabilities

6.11

4.93

5.99

8.15

8.81

Provisions

2.58

2.11

2.64

3.19

2.09

Net Current Assets

16.8

18.8

19.49

21.52

21.56

Miscellaneous Expenses not w/o

Total Assets

34.98

37.49

37.97

30.06

30.62

Contingent Liabilities

SANDU PHARMACEUTICALS LTD.

Enjoy Lifetime Free Delivery Trade